TITLE

BAS/BSCR52 Investigating the importance of heparan sulphate in determining endothelial progenitor cell function

AUTHOR(S)
Williamson, K.; Haque, S.; Bruce, I. N.; Stringer, S. E.; Alexander, M. Y.
PUB. DATE
September 2010
SOURCE
Heart;Sep2010, Vol. 96 Issue 17, pe27
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The increased risk of cardiovascular disease with age may, in part, be due to a decline in the function of endothelial progenitor cells (EPCs). Cell surface heparan sulphate proteoglycans (HSPGs) can bind a plethora of factors that are essential for EPC function. However, these interactions are dependent upon specific structures of HS. We aim to establish whether structural changes of HS on EPCs underlie the age-associated functional deterioration of these cells. The number and function of EPCs in patients with systemic lupus erythematosus (SLE), a disease associated with accelerated vascular ageing, was compared with age-matched healthy controls (52 patients and 30 controls; mean age 52 and 50 years, respectively). To enumerate EPCs, mononuclear cells were labelled with CD133 and CD34 and analysed by flow cytometry. The formation of colony-forming units (CFUs) after 7 days in culture was a measure of EPC function. Cell surface HS structure was analysed using high performance liquid chromatography. While EPC levels did not significantly differ, impairment in EPC function with vascular ageing was evident from the significantly reduced mean number of CFU (7 (SD=5) vs 17 (SD=18), p=0.01), with fewer large CFU (17% vs 40%; p<0.05) in patients than in controls. Preliminary data suggest decreased 2-O-sulphation of HS in association with vascular age. Ongoing studies are investigating if this affects EPC migration, proliferation and integration into vascular structures. Proving our hypothesis will improve our understanding of age-associated endothelial dysfunction and ascertain whether EPCs and/or HS oligosaccharides have therapeutic potential to attenuate age-associated vascular pathologies.
ACCESSION #
55416265

 

Related Articles

  • Circulating Endothelial Progenitor Cell Levels Are Not Reduced in HIV-Infected Men. Costiniuk, Cecilia T.; Hibbert, Benjamin M.; Filion, Lionel G.; Kovacs, Colin M.; Benko, Erika; O'Brien, Edward R.; Angel, Jonathan B. // Journal of Infectious Diseases;3/1/2012, Vol. 205 Issue 5, p713 

    Reduced levels of endothelial progenitor cells (EPCs) have been associated with increased cardiovascular (CV) risk, but limited data are available on EPC levels in the human immunodeficiency virus (HIV)-infected population. EPCs (CD45dim/CD34+/kinase domain receptor+) from 36 HIVuninfected and...

  • Epicardium-to-fat transition in injured heart. Liu, Qiaozhen; Huang, Xiuzhen; Duan, Shengzhong; Yu, Ying; Zhou, Bin; Oh, Jin-Hee; Lin, Ruei-Zeng; Melero-Martin, Juan M; Yang, Rui; Qiu, Ju; Pu, William T // Cell Research;Nov2014, Vol. 24 Issue 11, p1367 

    A letter to the editor is presented in response to the article "Epicardium-to-fat transition in injured heart" that was published in the September 26, 2014 issue.

  • Hepatocyte growth factor protects endothelial progenitor cell from damage of low-density lipoprotein cholesterol via the PI3K/Akt signaling pathway. XueJun Yu; MingBao Song; JianFei Chen; GuangXu Zhu; Gang Zhao; Hong Wang; Lan Hunag // Molecular Biology Reports;Jun2010, Vol. 37 Issue 5, p2423 

    Risk factors for coronary heart disease including low-density lipoprotein (LDL) cholesterol can reduce the number and activity of endothelial progenitor cells (EPCs), thereby hindering their usefulness for treating cardiovascular disease in transplants. The aim of this study was to investigate...

  • Cause or Effect of Arteriogenesis: Compositional Alterations of Microparticles from CAD Patients Undergoing External Counterpulsation Therapy. Al Kaabi, Ali; Traupe, Tobias; Stutz, Monika; Buchs, Natasha; Heller, Manfred; Yao Liang Tang // PLoS ONE;Oct2012, Vol. 7 Issue 10, Special section p1 

    Recently, a clinical study on patients with stable coronary artery disease (CAD) showed that external counterpulsation therapy (ECP) at high (300 mmHg) but not at low inflation pressure (80 mmHg) promoted coronary collateral growth, most likely due to shear stress-induced arteriogenesis. The...

  • Circulating endothelial cells in pediatric renal transplant recipients. Uslu Gökceoğlu, Arife; Akman, Sema; Köksoy, Sadi; Şahin, Emel; Koyun, Mustafa; Çomak, Elif; Doğan, Çağla; Akbaş, Halide; Dinçkan, Ayhan // Pediatric Nephrology;Dec2013, Vol. 28 Issue 12, p2377 

    Background: An increase in the number of circulating endothelial cells (CEC) indicates endothelial damage and the risk of cardiovascular disease. The aim of our study was to investigate the association of CEC with various clinical parameters in pediatric renal transplant recipients. Methods:...

  • Exposure to Ambient Air Fine Particulate Matter Prevents VEGF-Induced Mobilization of Endothelial Progenitor Cells from the Bone Marrow. Haberzettl, Petra; Lee, Jongmin; Duggineni, Dheeraj; McCracken, James; Bolanowski, Duane; O'Toole, Timothy E.; Bhatnagar, Aruni; Conklin, Daniel J. // Environmental Health Perspectives;Jun2012, Vol. 120 Issue 6, p848 

    Background: Exposure to ambient fine particulate matter air pollution (PM2.5; < 2.5 μm in aerodynamic diameter) induces endothelial dysfunction and increases the risk for cardiovascular disease. Endothelial progenitor cells (EPCs) contribute to postnatal endothelial repair and regeneration....

  • Tumor-dependent increase of serum amino acid levels in breast cancer patients has diagnostic potential and correlates with molecular tumor subtypes. Poschke, Isabel; Yumeng Mao; Rolf Kiessling; Jana de Boniface // Journal of Translational Medicine;2013, Vol. 11 Issue 1, p1 

    Background Malignancies induce changes in the levels of serum amino acids (AA), which may offer diagnostic potential. Furthermore, changes in AA levels are associated with immune cell function. In this study, serum AA levels were studied in breast cancer patients versus patients with benign...

  • Analysis of Prasugrel by Chromatography - Review. Housheh, Samer; Trefi, Saleh; Haroun, Mohammad; Chehna, M. Fawaz // International Journal of Pharmaceutical Sciences Review & Resear;Sep/Oct2014, Vol. 28 Issue 2, p180 

    Prasugrel, being a potent platelet aggregation inhibitor, is used widely around the world to reduce cardiovascular risks in patients with stroke, myocardial infarction, and atherosclerosis. The aim of this review firstly to focus on a comprehensive update of chromatography determination of...

  • Association of visceral fat with endothelial progenitor cell levels in prediabetes. Angelidi, A.; Protopsaltis, I.; Dimitriadou, A.; Kornezos, I.; Gritzapis, A.; Sergentanis, T.; Verras, C.; Kranidiotis, G.; Melidonis, A. // Scientific Chronicles / Epistimonika Chronika;Jan2013, p23 

    Background: Endothelial progenitor cells (EPCs) have recently been considered as a potential novel biomarker of vascular integrity, atherosclerosis and cardiovascular risk. Aim: This study was performed to investigate the main determinants of EPC levels in individuals with prediabetes. Materials...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics